COVID-19 treatments to enter the market with a hefty price tag

FILE - Doses of the anti-viral drug Paxlovid are displayed in New York, Aug. 1, 2022. The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag. Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost, for now.

Under a new agreement, reached last month between Pfizer and the federal government, people on Medicaid, Medicare or those who are without medical insurance will not pay any out-of-pocket costs for the treatment through the end of next year. Pfizer will also offer copay assistance for the treatment through 2028. The Department of Veterans Affairs, the Department of Defense and Indian Health Service will still be able to access Paxlovid the government has on hand.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

- Vivek Ramaswamy offers dubious figure for China’s role in supplying pharmaceutical ingredientsNASHUA, N.H. — Republican presidential candidate Vivek Ramaswamy, who as a venture capitalist has had business ties to C
Source: PolitiFact - 🏆 17. / 71 Read more »

‘Guided Missile Drugs’ Could Be Big Pharma’s Secret WeaponMerck, Pfizer are the latest big pharma companies to invest in this booming area
Source: WSJ - 🏆 98. / 63 Read more »

Pfizer Progresses Combo Covid Vaccine. It's Competing with Moderna.Pfizer and BioNTech said an early trial of a combined Covid-19 and influenza vaccine had produced positive data. The companies are set for a race with...
Source: MarketWatch - 🏆 3. / 97 Read more »